ERS clinical practice guidelines on treatment of sarcoidosis von Baughman, Robert P, Valeyre, Dominique, Korsten, Peter, Mathioudakis, Alexander G, Wuyts, Wim A, Wells, Athol, Rottoli, Paola, Nunes, Hiliaro, Lower, Elyse E, Judson, Marc A, Israel-Biet, Dominique, Grutters, Jan C, Drent, Marjolein, Culver, Daniel A, Bonella, Francesco, Antoniou, Katerina, Martone, Filippo, Quadder, Bernd, Spitzer, Ginger, Nagavci, Blin, Tonia, Thomy, Rigau, David, Ouellette, Daniel R

Volltext

Methotrexate vs Azathioprine in Second-line Therapy of Sarcoidosis von Vorselaars, Adriane D.M., MD, Wuyts, Wim A., MD, PhD, Vorselaars, Veronique M.M., MD, Zanen, Pieter, MD, PhD, Deneer, Vera H.M., PhD, Veltkamp, Marcel, MD, PhD, Thomeer, Michiel, MD, PhD, van Moorsel, Coline H.M., PhD, Grutters, Jan C., MD, PhD

Volltext

Nintedanib with Add-on Pirfenidone in Idiopathic Pulmonary Fibrosis. Results of the INJOURNEY Trial von Vancheri, Carlo, Kreuter, Michael, Richeldi, Luca, Ryerson, Christopher J, Valeyre, Dominique, Grutters, Jan C, Wiebe, Sabrina, Stansen, Wibke, Quaresma, Manuel, Stowasser, Susanne, Wuyts, Wim A

Volltext

BAL Cell Gene Expression Is Indicative of Outcome and Airway Basal Cell Involvement in Idiopathic Pulmonary Fibrosis von Prasse, Antje, Binder, Harald, Schupp, Jonas C, Kayser, Gian, Bargagli, Elena, Jaeger, Benedikt, Hess, Moritz, Rittinghausen, Susanne, Vuga, Louis, Lynn, Heather, Violette, Shelia, Jung, Birgit, Quast, Karsten, Vanaudenaerde, Bart, Xu, Yan, Hohlfeld, Jens M, Krug, Norbert, Herazo-Maya, Jose D, Rottoli, Paola, Wuyts, Wim A, Kaminski, Naftali

Volltext

Efficacy and safety of nintedanib in patients with advanced idiopathic pulmonary fibrosis von Richeldi, Luca, Kolb, Martin, Jouneau, Stéphane, Wuyts, Wim A, Schinzel, Birgit, Stowasser, Susanne, Quaresma, Manuel, Raghu, Ganesh

Volltext

Idiopathic Pulmonary Fibrosis: Best Practice in Monitoring and Managing a Relentless Fibrotic Disease von Wuyts, Wim A., Wijsenbeek, Marlies, Bondue, Benjamin, Bouros, Demosthenes, Bresser, Paul, Robalo Cordeiro, Carlos , Hilberg, Ole, Magnusson, Jesper, Manali, Effrosyni D., Morais, António, Papiris, Spyridon, Shaker, Saher, Veltkamp, Marcel, Bendstrup, Elisabeth

Volltext

Short and long-term effects of pulmonary rehabilitation in interstitial lung diseases: a randomised controlled trial von Perez-Bogerd, Silvia, Wuyts, Wim, Barbier, Veronica, Demeyer, Heleen, Van Muylem, Alain, Janssens, Wim, Troosters, Thierry

Volltext

The pathogenesis of pulmonary fibrosis: a moving target von WUYTS, Wim A, AGOSTINI, Carlo, PRASSE, Antje, ROBALO-CORDEIRO, Carlos, VERBEKEN, Eric, VERSCHAKELEN, Johny A, WELLS, Athol U, VERIEDEN, Geert M, ANTONIOU, Katerina M, BOUROS, Demosthenes, CHAMBERS, Rachel C, COTTIN, Vincent, EGAN, Jim J, LAMBRECHT, Bart N, LORIES, Rik, PARFREY, Helen

Volltext

Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseases von Cottin, Vincent, Hirani, Nikhil A, Hotchkin, David L, Nambiar, Anoop M, Ogura, Takashi, Otaola, María, Skowasch, Dirk, Park, Jong Sun, Poonyagariyagorn, Hataya K, Wuyts, Wim, Wells, Athol U

Volltext

Dyspnoea and cough in patients with systemic sclerosis-associated interstitial lung disease in the SENSCIS trial von Volkmann, Elizabeth R, Kreuter, Michael, Hoffmann-Vold, Anna M, Wijsenbeek, Marlies, Smith, Vanessa, Khanna, Dinesh, Denton, Christopher P, Wuyts, Wim A, Miede, Corinna, Alves, Margarida, Sambevski, Steven, Allanore, Yannick

Volltext

Antacid therapy and disease outcomes in idiopathic pulmonary fibrosis: a pooled analysis von Kreuter, Michael, Prof, Wuyts, Wim, MD, Renzoni, Elisabetta, MD, Koschel, Dirk, MD, Maher, Toby M, MD, Kolb, Martin, MD, Weycker, Derek, PhD, Spagnolo, Paolo, MD, Kirchgaessler, Klaus-Uwe, MD, Herth, Felix J F, MD, Costabel, Ulrich, MD

Volltext

Occupational interstitial lung diseases von Spagnolo, Paolo, Ryerson, Christopher J, Guler, Sabina, Feary, Johanna, Churg, Andrew, Fontenot, Andrew P, Piciucchi, Sara, Udwadia, Zarir, Corte, Tamera J, Wuyts, Wim A, Johannson, Kerri A, Cottin, Vincent

Volltext

Time for a change: is idiopathic pulmonary fibrosis still idiopathic and only fibrotic? von Wolters, Paul J, Blackwell, Timothy S, Eickelberg, Oliver, Loyd, James E, Kaminski, Naftali, Jenkins, Gisli, Maher, Toby M, Molina-Molina, Maria, Noble, Paul W, Raghu, Ganesh, Richeldi, Luca, Schwarz, Marvin I, Selman, Moises, Wuyts, Wim A, Schwartz, David A

Volltext

Impact of BAL lymphocytosis and presence of honeycombing on corticosteroid treatment effect in fibrotic hypersensitivity pneumonitis: a retrospective cohort study von De Sadeleer, Laurens J, Hermans, Frederik, De Dycker, Els, Yserbyt, Jonas, Verschakelen, Johny A, Verbeken, Eric K, Verleden, Geert M, Verleden, Stijn E, Wuyts, Wim A

Volltext

Riociguat for idiopathic interstitial pneumonia-associated pulmonary hypertension (RISE-IIP): a randomised, placebo-controlled phase 2b study von Nathan, Steven D, Behr, Jürgen, Collard, Harold R, Cottin, Vincent, Hoeper, Marius M, Martinez, Fernando J, Corte, Tamera J, Keogh, Anne M, Leuchte, Hanno, Mogulkoc, Nesrin, Ulrich, Silvia, Wuyts, Wim A, Yao, Zhen, Boateng, Francis, Wells, Athol U

Volltext

Gene correlation network analysis to identify regulatory factors in idiopathic pulmonary fibrosis von McDonough, John E, Kaminski, Naftali, Thienpont, Bernard, Hogg, James C, Vanaudenaerde, Bart M, Wuyts, Wim A

Volltext

Long-term treatment of patients with idiopathic pulmonary fibrosis with nintedanib: results from the TOMORROW trial and its open-label extension von Richeldi, Luca, Kreuter, Michael, Selman, Moisés, Crestani, Bruno, Kirsten, Anne-Marie, Wuyts, Wim A, Xu, Zuojun, Bernois, Katell, Stowasser, Susanne, Quaresma, Manuel, Costabel, Ulrich

Volltext

Combination therapy: the future of management for idiopathic pulmonary fibrosis? von Wuyts, Wim A, MD, Antoniou, Katerina M, Prof, Borensztajn, Keren, PhD, Costabel, Ulrich, Prof, Cottin, Vincent, Prof, Crestani, Bruno, MD PhD, Grutters, Jan C, Prof, Maher, Toby M, PhD, Poletti, Venerino, Prof, Richeldi, Luca, MD, Vancheri, Carlo, MD PhD, Wells, Athol U, Dr

Volltext

Health-related quality of life and symptoms in patients with IPF treated with nintedanib: analyses of patient-reported outcomes from the INPULSIS® trials von Kreuter, Michael, Wuyts, Wim A, Wijsenbeek, Marlies, Bajwah, Sabrina, Maher, Toby M, Stowasser, Susanne, Male, Natalia, Stansen, Wibke, Schoof, Nils, Orsatti, Leticia, Swigris, Jeffrey

Volltext

Diagnostic Ability of a Dynamic Multidisciplinary Discussion in Interstitial Lung Diseases: A Retrospective Observational Study of 938 Cases von De Sadeleer, Laurens J, Meert, Caressa, Yserbyt, Jonas, Slabbynck, Hans, Verschakelen, Johny A, Verbeken, Eric K, Weynand, Birgit, De Langhe, Ellen, Lenaerts, Jan L, Nemery, Benoit, Van Raemdonck, Dirk, Verleden, Geert M, Wells, Athol U, Wuyts, Wim A

Volltext